Most recently, it has been identified that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in similar regions as classical opioid receptors, it binds to the wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts being a scavenger https://evansh272vdu4.therainblog.com/profile